Despite 100-year since its discovery, insulin – a life-saving medicine – remains inaccessible to millions around the world, owing to limited availability and high cost. Insulin is manufactured in just 20 countries worldwide, leaving all the other countries dependent on imports to meet the needs of their patients with diabetes.

In a newly published research study in the esteemed Science Magazine, Precision’s Abhishek Sharma and co-author Warren Kaplan use an innovative linkage of two global datasets to answer two questions: From where do countries with no domestic production source their insulin? And of these countries, are their present levels of insulin imports sufficient to treat the in-country number of persons with diabetes? Authors highlight the unmet need, regulatory and health system challenges, market-shaping opportunities, and offer recommendations for improving access.

Read the full study here!

To receive the full-text copy of the study, feel free to email Abhishek at Abhishek.sharma@precisionvh.com.